Myoepithelial Carcinoma Ex Pleomorphic Adenoma of the Maxillary Sinus: A Case Report and Review of Literature.

Head Neck Pathol

Department of Surgery and Biomedical Sciences, Section of Maxillo-Facial Surgery, University of Perugia, Piazzale Gambuli 1, 06129, Perugia, Italy.

Published: December 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Myoepithelial carcinoma ex pleomorphic adenoma is defined as a malignant epithelial neoplasm arising from a primary or recurrent benign pleomorphic adenoma. This type of tumor comprises 3.6% of all salivary gland tumors and 12% of malignant ones. Clinically, it most commonly presents as a firm mass in the parotid gland. The development of this neoplasm in the sinonasal and nasopharyngeal regions is extremely rare and only few cases are reported in the literature. The prognosis of myoepithelial carcinoma is variable. Marked cellular pleomorphism, high mitotic rate, and high proliferative activity correspond to a poor prognosis. In this article, the authors report the histopathological features of a clinical case of a 64-years-old patient with a large median maxillary neoplasm diagnosed as myoepithelial carcinoma/ex-pleomorphic adenoma. The tumor was resected and subjected to secondary reconstruction using a revascularized free fibula flap. The myoepithelial derivation of neoplastic cells was demonstrated by immunohistochemical positivity for S-100 protein (strong and diffuse), cytokeratin 14 (strong and diffuse), and GFAP (focal).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633205PMC
http://dx.doi.org/10.1007/s12105-020-01282-5DOI Listing

Publication Analysis

Top Keywords

myoepithelial carcinoma
12
pleomorphic adenoma
12
carcinoma pleomorphic
8
strong diffuse
8
myoepithelial
5
adenoma
4
adenoma maxillary
4
maxillary sinus
4
sinus case
4
case report
4

Similar Publications

Myoepithelial Carcinoma Ex-Pleomorphic Adenoma Exposing a RET Germline Mutation: A Rare Genetic Event.

Head Neck Pathol

September 2025

Department of Laboratory Medicine and Pathology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.

Myoepithelial carcinoma (MECA) is a malignant neoplasm composed exclusively of myoepithelial cells and accounts for less than 1% of all salivary gland tumors. Its diagnosis is often challenging due to histologic overlaps with benign lesions and its variable morphologic presentation. Although molecular profiling has emerged as a valuable tool in salivary gland tumor classification, the genetic landscape of MECA remains incompletely defined.

View Article and Find Full Text PDF

p63 immunohistochemical expression in tumor cells of high-grade invasive breast carcinomas on core biopsy: a potential diagnostic pitfall.

Ann Diagn Pathol

August 2025

Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Anatomic Pathology, University of Catania, 95123 Catania, Italy. Electronic address:

In breast pathology, p63 is a highly specific myoepithelial marker, crucial for distinguishing in situ from invasive lesions. Its expression is characteristically absent in the neoplastic cells of invasive carcinoma. However, in our diagnostic experience focal p63 expression in neoplastic cells of some high-grade breast tumors has been observed.

View Article and Find Full Text PDF

Primary endobronchial epithelial-myoepithelial carcinoma: A case report and literature review.

Exp Ther Med

October 2025

Department of Blood Transfusion Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China.

Pulmonary epithelial-myoepithelial carcinoma (P-EMC) is a rare type of salivary gland tumour of the lung. Due to its rarity and lack of long-term follow-up data, there is no established standard for optimal treatment or duration of follow-up. The present study reports the case of a 58-year-old female patient with P-EMC originating from the middle part of the bronchus and presenting as an endobronchial mass in the left superior lobe.

View Article and Find Full Text PDF

Myoepithelial carcinoma of the uterine corpus with EWSR1::ZNF444 fusion: a case report.

Virchows Arch

September 2025

Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.

Myoepithelial carcinoma (MECA) is a rare malignant tumor showing myoepithelial differentiation, most commonly found in the salivary glands and soft tissue, with only isolated reports in the female genital tract. We report the first documented case of uterine MECA harboring an EWSR1::ZNF444 fusion. A 55-year-old woman with a history of breast cancer presented with abnormal uterine bleeding.

View Article and Find Full Text PDF

Objective: To describe extracellular matrix (ECM) components in salivary gland tumors with and without myoepithelial differentiation.

Design: Five cases of each tumor type were analyzed: pleomorphic adenoma, myoepithelioma, adenoid cystic carcinoma, myoepithelial carcinoma, epithelial-myoepithelial carcinoma, and salivary duct carcinoma. Histochemical stains identified collagen fibers, elastin, proteoglycans (PG), and glycosaminoglycans (GAG).

View Article and Find Full Text PDF